Takeda Pharmaceutical Income Statement (2017-2026) | TAK

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	8.67B	7.67B	7.93B	8.37B	7.52B	7.26B	7.76B	8.00B	7.72B	22.25B	7.11B	8.15B	7.76B	23.65B	6.93B	7.92B	8.13B	23.95B	7.11B	6.98B
Cost of Revenue (Quarter)	2.20B	2.51B	2.48B	2.52B	2.26B	2.21B	2.38B	2.43B	2.34B	7.23B	2.59B	2.61B	2.49B	8.03B	2.52B	2.54B	2.73B	8.13B	2.64B	2.59B
Gross Profit (Quarter)	6.47B	5.17B	5.45B	5.85B	5.39B	15.47B	4.58B	5.58B	5.10B	15.02B	4.52B	5.54B	5.02B	15.62B	4.42B	5.38B	5.40B	15.81B	4.48B	4.39B
Operating items
Amortization - Intangibles (Quarter)					-0.96B	-2.68B	-0.81B	-0.93B	-0.95B	-2.68B	-0.91B	-0.94B	-0.89B	-2.76B	-0.90B	-0.91B	-0.96B	-2.79B	-0.89B	8.42B
Research & Development (Quarter)	-1.12B	-1.20B	-1.13B	-1.24B	-1.11B	-1.12B	-1.24B	-1.23B	-1.19B	-1.27B	-1.27B	8.53B	-1.08B	-1.18B	-1.12B	8.16B	-0.99B	-1.10B	-1.14B	7.37B
Selling, General & Administrative (Quarter)	-2.01B	-1.93B	-2.03B	-1.99B	-1.79B	-1.80B	-1.86B	-1.88B	-1.81B	-1.75B	-1.81B	5.76B	-1.73B	-1.80B	-1.78B	5.76B	-1.77B	-1.72B	-1.84B	5.21B
Other Operating Expenses (Quarter)					0.98B	-2.46B	1.29B	1.23B	1.15B	-2.30B	1.15B	-16.11B	1.09B	-2.45B	0.95B	-15.69B	0.91B	-2.67B	1.05B
Operating Expenses (Quarter)	-3.13B	-3.12B	-3.16B	-3.23B	-1.92B	-5.38B	-1.80B	-1.88B	-1.85B	-5.32B	-1.93B	-1.82B	-1.72B	-5.42B	-1.95B	-1.77B	-1.85B	-5.49B	-1.92B	12.58B
Operating Income (Quarter)	2.27B	0.89B	1.02B	2.14B	1.16B	0.76B	1.04B	1.27B	1.23B	2.78B	0.60B	1.14B	1.07B	2.80B	-0.49B	1.21B	1.27B	2.87B	-2.70B	-2.65B
EBIT (Quarter)	2.27B	0.89B	1.02B	2.14B	1.16B	0.76B	1.04B	1.27B	1.23B	2.78B	0.60B	1.14B	1.07B	2.80B	-0.49B	1.21B	1.27B	2.87B	-2.70B	-2.65B
Non-operating items
Interest & Investment Income (Quarter)	0.42B	0.06B	0.04B	-0.17B	0.47B	0.11B	0.30B	0.46B	0.19B	0.38B	0.09B	0.21B	0.20B	0.31B	0.12B	0.48B	0.31B	1.40B	0.12B	0.03B
Other Non Operating Income (Quarter)
Non Operating Income (Quarter)				-0.22B				-0.25B
Net income details
EBT (Quarter)	2.04B	0.56B	0.64B	1.92B	1.20B	0.47B	0.76B	1.18B	0.99B	2.27B	0.32B	0.92B	0.88B	1.89B	-0.71B	0.99B	0.83B	2.12B	-2.96B	-2.90B
Tax Provisions (Quarter)	-0.78B	-0.14B	-0.13B	-0.73B	-0.39B	-0.02B	0.08B	-0.38B	-0.33B	0.32B	0.30B	-0.31B	-0.27B	-0.48B	0.29B	-0.27B	-0.28B	-0.65B	0.56B	0.68B
Profit After Tax (Quarter)	1.26B	0.42B	0.51B	1.18B	0.81B	2.07B	0.84B	0.79B	0.65B	1.98B	0.21B	0.64B	0.61B	1.42B	-0.68B	0.81B	0.86B	1.47B	-0.67B	-2.35B
Equity Income (Quarter)
Income from Non-Controlling Interests (Quarter)	0.00B	0.00B	0.00B	-0.00B	0.00B	-0.00B	0.00B		0.00B	-0.00B		-0.00B	0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	0.00B
Income from Continuing Operations (Quarter)	2.82B	0.70B	0.76B	2.65B	1.59B	0.49B	0.67B	1.56B	1.32B	1.94B	0.02B	1.23B	1.14B	2.37B	-1.00B	1.26B	1.10B	2.78B	-3.52B	-3.58B
Consolidated Net Income (Quarter)	2.82B	0.70B	0.76B	2.65B	1.59B	0.49B	0.67B	1.56B	1.32B	1.94B	0.02B	1.23B	1.14B	2.37B	-1.00B	1.26B	1.10B	2.78B	-3.52B	-3.58B
Income towards Parent Company (Quarter)	1.26B	0.42B	0.51B	-0.10B	0.81B	0.45B	0.84B	0.79B	0.65B	1.98B	0.21B	0.64B	0.61B	1.42B	-0.68B	0.81B	0.64B	1.47B	-2.39B	-2.35B
Net Income towards Common Stockholders (Quarter)	1.26B	0.42B	0.51B	-0.10B	0.81B	0.76B	0.84B	0.79B	0.65B	0.62B	0.21B	0.64B	0.61B	1.42B	-0.68B	0.81B	0.64B	1.47B	-2.39B	-2.35B
Additional items
EPS (Basic) (Quarter)	0.14	0.04	0.05	-0.06	0.09	0.07	0.06	0.51	0.06	0.05	0.01	0.41	0.39	0.90	-0.43	0.52	0.40	0.93	-1.52	-1.49
EPS (Diluted) (Quarter)	0.80	0.26	0.32	-0.06	0.52	0.49	0.54	0.51	0.42	0.39	0.13	0.41	0.39	0.88	-0.42	0.51	0.40	0.92	-1.50	-1.49
Shares Outstanding (Quarter)	9.18B	9.30B	10.89B	1.56B	8.64B	11.33B	14.24B	1.55B	10.62B	12.71B	15.57B	1.56B	1.56B	1.58B	1.58B	1.58B	1.58B	1.57B	1.57B	1.58B
Shares Outstanding (Diluted) (Quarter)	1.57B	1.58B	1.58B	1.58B	1.55B	1.56B	1.57B	1.57B	1.57B	1.57B	1.59B	1.58B	1.58B	1.60B	1.60B	1.61B	1.61B	1.60B	1.60B	1.58B
EBITDA (Quarter)	2.27B	0.89B	1.02B	2.14B	1.16B	0.76B	1.04B	1.27B	1.23B	2.78B	0.60B	1.14B	1.07B	2.80B	-0.49B	1.21B	1.27B	2.87B	-2.70B	-2.65B
Interest Expenses (Quarter)	-0.65B	-0.36B	-0.41B	2.67B	-0.43B	-0.39B	-0.56B	-0.45B	-0.43B	-1.20B	-0.33B	-0.40B	-0.38B	-1.16B	-0.33B	-0.70B	-0.57B	-2.13B	-0.35B	0.94B
Tax Rate (Quarter)	-38.23%	-25.15%	-19.91%	-38.25%	-32.45%	-4.36%	11.20%	-32.48%	-33.79%	14.33%	92.90%	-33.38%	-30.24%	-25.18%	-41.47%	-27.42%	-33.42%	-30.83%	-19.03%	-23.33%

Research Tools

Developers

Takeda Pharmaceutical Income Statement (2017-2026) | TAK

Research Tools

Developers

Takeda Pharmaceutical Income Statement (2017-2026) | TAK

Create an account

Sign In

Reset Password